Activin and Inhibin

EA4, a derivative of quinone, is an inhibitor for both rPLA and cPLA . EA4 can inhibit rPLA 2 with a K i value of 130 μM. EA4 can be used for the research of hemostasis, thrombosis, and erythropoiesisIn VitroEA4 (9 μM, 24 μM) inhibits both rPLA 2

EA4, a derivative of quinone, is an inhibitor for both rPLA and cPLA . EA4 can inhibit rPLA 2 with a K i value of 130 μM. EA4 can be used for the research of hemostasis, thrombosis, and erythropoiesisIn VitroEA4 (9 μM, 24 μM) inhibits both rPLA 2

EA4, a derivative of quinone, is an inhibitor for both rPLA and cPLA . EA4 can inhibit rPLA 2 with a K i value of 130 μM. EA4 can be used for the research of hemostasis, thrombosis, and erythropoiesisIn VitroEA4 (9 μM, 24 μM) inhibits both rPLA 2

EA4, a derivative of quinone, is an inhibitor for both rPLA and cPLA . EA4 can inhibit rPLA 2 with a K i value of 130 μM. EA4 can be used for the research of hemostasis, thrombosis, and erythropoiesisIn VitroEA4 (9 μM, 24 μM) inhibits both rPLA 2

EBNA1-IN-SC7 (compound SC7) is a selective Epstein-Barr nuclear antigen 1 ( EBNA1 ) inhibitor that interferes with EBNA1-DNA binding activity with an IC 50 value of 23 μM. EBNA1-IN-SC7 is used in EBV (Epstein-Barr virus)-related cancer research.In

Ebopiprant (OBE022) is an oral and selective prostaglandin F 2α ( PGF 2α ) receptor antagonist, with K i s of 1 nM, 26 nM for human and rat FP receptors, respectively.In VitroEbopiprant (OBE022) and OBE002 are assayed for FP binding affinity by

Ebopiprant (OBE022) is an oral and selective prostaglandin F 2α ( PGF 2α ) receptor antagonist, with K i s of 1 nM, 26 nM for human and rat FP receptors, respectively.In VitroEbopiprant (OBE022) and OBE002 are assayed for FP binding affinity by

Ebopiprant (OBE022) is an oral and selective prostaglandin F 2α ( PGF 2α ) receptor antagonist, with K i s of 1 nM, 26 nM for human and rat FP receptors, respectively.In VitroEbopiprant (OBE022) and OBE002 are assayed for FP binding affinity by

Ecopipam (SCH 39166) hydrobromide is a potent, selective and orally active antagonist of dopamine D1/D5 receptor , with K i s of 1.2 nM and 2.0 nM, respectively. Ecopipam hydrobromide shows more than 40-flod selectivity over D2, D4, 5-HT, and α2a

Ecopladib is a sub-micromolar inhibitor of cytosolic phospholipase A2α (cPLA2α) , with IC 50 s of 0.15 μM and 0.11 μM in the GLU micelle and rat whole blood assays, respectively.In VitroEcopladib inhibits cPLA2α in the PAPE liposome assay at 73% at

Edasalonexent (CAT-1004) is an orally bioavailable NF-κB inhibitor.In VitroEdasalonexent is an orally administered small molecule in which salicylic acid and docosahexaenoic acid (DHA) are covalently conjugated through an ethylenediamine linker and

Edasalonexent (CAT-1004) is an orally bioavailable NF-κB inhibitor.In VitroEdasalonexent is an orally administered small molecule in which salicylic acid and docosahexaenoic acid (DHA) are covalently conjugated through an ethylenediamine linker and